Sbalzarini G, Malusardi G, Pandolfi C, Cerri A
I Divisione Medica, U.S.S.L. n. 56, Lodi.
Minerva Med. 1990 May;81(5):403-5.
The literature reports conflicting results on ototoxicity, one of the best known adverse effects of cis-platinum. An audiometric study was therefore performed in patients treated with this drug for tumours of the head and neck. The possible hearing loss does not rule out the use of cis-platinum in our experience.